Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning
October 2009
by Tanvir Singh, MD; Ashwin Prakash, MD; Theodore Rais, MD; and Neeta Kumari, MD, MPH
Dr. Singh is Assistant Professor, Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; Dr. Prakash is from the Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; Dr. Rais is Associate Professor, Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; and Dr. Kumari is from the Department of Public Health, University Toledo Medical Center, Toledo, Ohio.
Psychiatry (Edgemont) 2009;6(10):30–34
Popularity: unranked [?]
Related posts
- Yoga as a Complementary Therapy for Children and Adolescents: A Guide for Clinicians
- Nonsuicidal Self injury in Adolescents
- Adolescent Depression: An Update and Guide to Clinical Decision-Making
- Warfarin and Antidepressants: Happiness without Hemorrhaging
- Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study
- Tramadol: Seizures, Serotonin Syndrome, and Coadministered Antidepressants
- Use of Benzodiazepines in the Treatment of Anxiety
- Real-World Data on SSRI Antidepressant Side Effects
- Treatment of Schizoaffective Disorder
- Generic Penetration in the Retail Antidepressant Market
Posted in Original Research | No Comments »
